These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3124343)

  • 1. The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse.
    Jansson L; Sandler S
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):225-30. PubMed ID: 3124343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloxan-induced diabetes in the mouse: time course of pancreatic B-cell destruction as reflected in an increased islet vascular permeability.
    Jansson L; Sandler S
    Virchows Arch A Pathol Anat Histopathol; 1986; 410(1):17-21. PubMed ID: 3097948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular permeability of pancreatic islets after administration of streptozotocin.
    Sandler S; Jansson L
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):359-67. PubMed ID: 2413613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciamexon in the low dose streptozotocin induced diabetes of mice.
    Linn T; Volkmann A; Germann H; Woehrle M; Bretzel RG; Bicker U; Federlin K
    Diabetes Res; 1987 Nov; 6(3):113-7. PubMed ID: 3325216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immune-mediated low-dose streptozotocin diabetes by agents which reduce vascular permeability.
    Schwab E; Burkart V; Freytag G; Kiesel U; Kolb H
    Immunopharmacology; 1986 Aug; 12(1):17-21. PubMed ID: 3531086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse.
    Sandler S
    Diabetologia; 1984 May; 26(5):386-8. PubMed ID: 6234194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: beta cell-toxicity and rebound of insulitis after cessation of treatment.
    Sai P; Maugendre D; Loreal O; Maurel C; Pogu S
    Diabete Metab; 1988; 14(4):455-62. PubMed ID: 3066654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclosporin on pancreatic events and development of diabetes in BB/Edinburgh rats.
    Bone AJ; Walker R; Varey AM; Cooke A; Baird JD
    Diabetes; 1990 Apr; 39(4):508-14. PubMed ID: 2180761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetogenic action of streptozotocin: essential role of membrane permeability.
    Beppu H; Maruta K; Kürner T; Kolb H
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):90-5. PubMed ID: 2949474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin enhances diabetes induced by low-dose streptozotocin treatment in mice.
    Sestier C; Odent-Pogu S; Bonneville M; Maurel C; Lang F; Sai P
    Immunol Lett; 1985; 10(1):57-60. PubMed ID: 3159656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of aloe carboxypeptidase fraction on streptozotocin-induced enhancement of vascular permeability in the pancreatic islets.
    Beppu H; Shimpo K; Chihara T; Tamai I; Nomoto-Yamaji S; Ozaki S; Ito S; Kuzuya H
    Phytomedicine; 2006 Jan; 13(1-2):49-60. PubMed ID: 16360933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effects of cyclosporin on diabetes in NOD mice.
    Mori Y; Suko M; Okudaira H; Matsuba I; Tsuruoka A; Sasaki A; Yokoyama H; Tanase T; Shida T; Nishimura M
    Diabetologia; 1986 Apr; 29(4):244-7. PubMed ID: 3519340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of cyclosporin A on cultured mouse pancreatic islets.
    Andersson A; Borg H; Hallberg A; Hellerström C; Sandler S; Schnell A
    Diabetologia; 1984 Jul; 27 Suppl():66-9. PubMed ID: 6383922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
    Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
    Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early insulitis and the islet vascular system.
    Papaccio G
    Diabetologia; 1993 Jul; 36(7):682-3. PubMed ID: 8359588
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of (-)15-deoxyspergualin on pancreatic islet B-cell function in vitro and on the development of diabetes after multiple low dose streptozotocin administration.
    Strandell E; Andersson A; Groth CG; Sandler S
    Pharmacol Toxicol; 1989 Aug; 65(2):114-8. PubMed ID: 2530505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.